Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of levetiracetam and piracetam for severe breath-holding spells
IRCT20190208042654N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levetiracetam and piracetam in Breath-holding spell (BHS) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Mar 2019; status: completed.
02
Drugs
levetiracetampiracetam
03
Conditions
Breath-holding spell (BHS)
Beyond the preview
Go deeper on IRCT20190208042654N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190208042654N1.